ProductsLogo
LogoStudy Documents
LogoAI Grader
LogoAI Answer
LogoAI Code Checker
LogoPlagiarism Checker
LogoAI Paraphraser
LogoAI Quiz
LogoAI Detector
PricingBlogAbout Us
logo

CNVs in Obesity among Caucasians

Verified

Added on  2023/05/30

|7
|1575
|319
AI Summary
This critical review explores the relationship between Copy Number Variations (CNVs) and obesity among Caucasians. The study examines the impact of AMY1, ARFRP1, and 22q11.2 on obesity and the technological platforms used to determine the genetic variants and their functional consequences.

Contribute Materials

Your contribution can guide someone’s learning journey. Share your documents today.
Document Page
CNVs in Obesity among Caucasians 1
A CRITICAL REVIEW: CNVs IN OBESITY AMONG CAUCASIANS
By [Name]
Course
Professor’s Name
Institution
Location of Institution
Date

Secure Best Marks with AI Grader

Need help grading? Try our AI Grader for instant feedback on your assignments.
Document Page
CNVs in Obesity among Caucasians 2
Introduction
Obesity is defined as an abnormal accumulation of fats that is risky to the overall health
of an individual (WHO, 2015). Health specialists measure the Body Mass Index (BMI) to
determine whether an individual is obese, overweight or has an average weight. BMI is
calculated by dividing the weight of a person by the square of the height. An individual with
30kg/m2 of BMI is obese. Obesity is a risk factor for numerous complications like cancer,
cardiovascular diseases, and diabetes (Esser et al., 2014). Copy Number Variation (CNS),
especially the Amylase Gene (AMY1) in the saliva either increases or lowers the chances of
obesity among the Caucasians. This paper will critically review CNVs in obesity among the
Caucasians.
Subject Characteristics
In the first article, the investigators selected a population of young adults from Portugal
to establish the relationship between CNVs and Obesity. The study involved 262 participants.
Out of the total number, 107 individuals were males while the remaining 155 participants were
females (Pinho, Padez, and Manco, 2018). The mean age of the participants was 21.08. Out of
the total number of participants, 22 individuals fall under the obese category. The obese
individuals had a BMI of 30kg/m2 or more than that measurement (Di Angelantonio et al., 2016).
64 participants were overweight according to the cut-off points that WHO defined. According to
WHO, an overweight individual is one with a BMI ranging from 25kg/m2 to 29.9kg/m2 (Mata,
and Jasul 2017). The remaining 176 individuals acted as a control to the experiment. In the
second article, the subjects included 207 Canadians with 96 of them being males and the rest
females (Voll et al., 2017). The median age of the participants was 26.7 years. The researchers
relied on molecular methods to confirm the 22q11.2 deletions. In the third article, the study
Document Page
CNVs in Obesity among Caucasians 3
population comprised of 779 Italian Children (Marcovecchio et al., 2016). Out of the 779
children, 744 accepted to take part in the survey. Therefore, there were 390 girls and 354 boys.
The average age of the participants was approximately 8.4 years. The investigators applied
molecular methods to determine the content of AMY1 in the participants. In the forth article,
group of subject consisted of 435 individuals with obesity (Hasstedt et al., 2015). The
participants had a BMI of 35.5kg/m2 and above. The experiment aimed to establish the
relationship between obesity and ARFRP1.
Technological Platforms used
In the first article, the researchers extracted DNA from the participants, the amplified the
genetic materials using Polymerase Chain Reaction (PCR) kits. The investigators started by
using TaqMan assays to target the AMY1 gene (Pinho et al., 2018). The RNASE assay, which
acts a reference helped in the evaluation of the quantity of AMY1 in the ddPCR system. After
obtaining the DNA samples from the participants, the researchers digested them to separate the
tandem copies. In the second article, the researchers applied standard molecular ways to confirm
the 22q11.2 deletion. To determine the relationship between low AMY1 and obesity in the third
article, the researchers extracted DNA from saliva samples (Marcovecchio et al., 2016). The
researchers extracted DNA using QIAmp kit. Furthermore, the investigators used quantitative
PCR to amplify the AMY1 copies. The qPCR contained two TaqMan assays. To establish the
relationship between obesity and ARFRP1 in the fourth article, the researchers applied dublex
TaqMan assay and qPCR (Hasstedt et al., 2015). The researchers used QIAmp Blood kit to
extract DNA. The investigators performed Microassay analysis and scanned the slides using a
scanner called RocheNimblegenMS200Microarray.
Genetic Variants and their Functional Consequences
Document Page
CNVs in Obesity among Caucasians 4
The first gene variant associated with obesity is AMY1. The amylase gene is located at
the salivary glands, and it assists in the digestion of carbohydrates in the mouth. An individual
who has a functional metabolism of carbohydrates can maintain a normal weight (Pinho et al.,
2018). However, accumulation of sugars due to improper digestion by the amylases leads to the
onset of obesity. Therefore, a person with high amounts of AMY1 can maintain an average
weight due to proper metabolism. Low levels of AMY1 elevate the BMI of an individual while
high AMY1 decreases the BMI (Marcovecchio et al., 2016). The second gene variant associated
with obesity is ARFRP1 which is located at chromosome 20q13.3. Recent research has shown
that the ARFRP1 controls both chylomicron formation and lipid droplets. Additionally, the CNV
assist in glucose digestion. Thus, ARFRP1 facilitates the metabolism of both fats and
carbohydrates. An individual with functional and sufficient amounts of ARFRP1 can maintain a
normal weight due to effective digestion (Hasstedt et al., 2015). Consequently, insufficient levels
of ARFRP1 lead to the onset of obesity due to ineffective digestion. The third gene variant
associated with obesity is 22q11.2. The deletion of CNV 22q11.2 (22q11.2DS) leads to the
beginning of obesity (Voll et al., 2017). 22q11.2DS not only causes obesity but also leads to the
development of Schizophrenia, hypothyroidism, and intellectual disability.
Conclusion
Obesity is defined as the excessive accumulation of fats that poses a health risk to an
individual. A study involving young Caucasians indicated that high levels of AMY1 lead to the
maintenance of normal weight. Additionally, the reduction in AMY1 leads to the onset of
obesity. The investigators digested the DNA samples from the participants before amplifying the
strands using PCR. The results of the study indicated that low AMY1 elevates BMI. Apart from
AMY1, ARFRP1 and 22q11.2 are also associated with obesity. Increased levels of ARFRP1

Paraphrase This Document

Need a fresh take? Get an instant paraphrase of this document with our AI Paraphraser
Document Page
CNVs in Obesity among Caucasians 5
reduce the chances of obesity. Similarly, 22q11.2DS causes obesity and other complications like
hypothyroidism and schizophrenia.
References
Di Angelantonio, E., Bhupathiraju, S.N., Wormser, D., Gao, P., Kaptoge, S., de Gonzalez, A.B.,
Cairns, B.J., Huxley, R., Jackson, C.L., Joshy, G. and Lewington, S., 2016. Body-mass index and
all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four
continents. The Lancet, 388(10046), pp.776-786.Retrieved from:
https://www.ncbi.nlm.nih.gov/pubmed/27423262
Document Page
CNVs in Obesity among Caucasians 6
Esser, N., Legrand-Poels, S., Piette, J., Scheen, A.J. and Paquot, N., 2014. Inflammation as a link
between obesity, metabolic syndrome and type 2 diabetes. Diabetes research and clinical
practice, 105(2), pp.141-150. Retrieved from:
https://insulinresistance.org/index.php/jir/article/view/30/88
Hasstedt, Sandra J., Yuanpei Xin, Rong Mao, Tracey Lewis, Ted D. Adams, and Steven C. Hunt.
"A copy number variant on chromosome 20q13. Three implicated in thinness and severe
obesity." Journal of obesity 2015 (2015). Retrieved from:
https://www.hindawi.com/journals/jobe/2015/623431/
Marcovecchio, M.L., Florio, R., Verginelli, F., De Lellis, L., Capelli, C., Verzilli, D., Chiarelli,
F., Mohn, A. and Cama, A., 2016. Low AMY1 gene copy number is associated with the
increased body mass index in prepubertal boys. PloS one, 11(5), p.e0154961.Retrieved from:
https://www.ncbi.nlm.nih.gov/pubmed/27149670
Mata, A. and Jasul Jr, G., 2017. Prevalence of Metabolic Syndrome and its Features Across
Different (Normal, Overweight, Pre-Obese and Obese) Body Mass Index (BMI) Categories in a
Tertiary Hospital in the Philippines. Journal of the ASEAN Federation of Endocrine Societies,
32(2), p.117. Retrieved from: asean-endocrinejournal.org/index.php/JAFES/article/view/414
Pinho, S., Padez, C. and Manco, L., 2018. High AMY1 copy number protects against obesity in
Portuguese young adults. Annals of human biology, pp.1-5. DOI:
10.1080/03014460.2018.1490452
Document Page
CNVs in Obesity among Caucasians 7
Voll, S.L., Boot, E., Butcher, N.J., Cooper, S., Heung, T., Chow, E.W., Silversides, C.K. and
Bassett, A.S., 2017. Obesity in adults with 22q11. 2 deletion syndrome. Genetics in Medicine,
19(2), p.204. Retrieved from:
https://www.ncbi.nlm.nih.gov/pubmed/27537705
World Health Organization, 2015. Health Topics: Obesity World Health Organization. Retrieved
from:
https://www.who.int/topics/obesity/en/
1 out of 7
[object Object]

Your All-in-One AI-Powered Toolkit for Academic Success.

Available 24*7 on WhatsApp / Email

[object Object]